Kodiak Sciences has released 20-week follow-up data from the APEX study, evaluating KSI-101 in patie...

PolyActiva and RareSight have officially announced a strategic research collaboration to develop fir...

Sydnexis has announced that its partner, Santen, has received regulatory approval from the UK Medici...

Opus Genetics has announced a key regulatory milestone in the development of its gene therapy candid...

4D Molecular Therapeutics has reported promising long-term results from its Phase 1/2 PRISM clinical...

LambdaVision has secured $7 million in seed funding to support the preclinical development and produ...

Nanoscope Therapeutics has reported five-year long-term safety results from its EXTEND study, reinfo...

Tenpoint Therapeutics has announced the submission of a New Drug Application (NDA) for Brimochol PF,...

The Enova Advanced® Extended Depth of Focus (EDoF) IOL, developed by VSY Biotechnology GmbH, represe...

Ocular Therapeutix has achieved its randomization goal of 555 patients in SOL-R, the company’s secon...